Business Briefing: F.D.A. Clears Cheaper Version of Johnson & Johnson Biologic

Federal officials have approved a cheaper version of Johnson & Johnson’s blockbuster drug Remicade, a biotech medicine for inflammatory diseases.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Johnson & Drugs (Pharmaceuticals) Food and Drug Administration Remicade (Drug) Celltrion Biotechnology and Bioengineering Pfizer Inc Generic Brands and Products Source Type: news